(VIANEWS) – The NASDAQ ended the session with Merrimack Pharmaceuticals rising 8.97% to $5.10 on Thursday, after two sequential sessions in a row of gains. NASDAQ Composite rose 1.73% to $14,823.43, following the last session’s upward trend on what was an all-around up trend trading session today.


Today’s last reported volume for Merrimack Pharmaceuticals is 23082, 11.12% above its average volume of 20772.

Merrimack Pharmaceuticals’s last close was $4.68, 50.48% below its 52-week high of $9.45.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Merrimack Pharmaceuticals’s stock is considered to be oversold (<=20).

Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $5.10 at 17:20 EST, way under its 52-week high of $9.45 and way higher than its 52-week low of $3.56.

Merrimack Pharmaceuticals’s Moving Average

Merrimack Pharmaceuticals’s worth is way above its 50-day moving average of $4.61 and way under its 200-day moving average of $5.83.

More news about Merrimack Pharmaceuticals (MACK).


Please enter your comment!
Please enter your name here